scorecardresearch
Add as a preferred source on Google
Wednesday, November 26, 2025
TopicICMR

Topic: ICMR

India’s Covid tally rises to 1.04 crore with 18,139 new infections in a day

A total of 1,00,37,398 people have recuperated from the virus while the death toll has increased to 1,50,570 as 234 people succumbed to the disease in the last 24 hours.

Plasma therapy, if given early, could curb severe Covid symptoms in the elderly, study finds

The study in NEJM, conducted by Argentina-based non-profit, used convalescent plasma for the treatment of elderly Covid patients before severe symptoms develop.

India registers 16,504 new Covid cases, recoveries surge to 99.46 lakh

While the death toll increased to 1,49,649 with 214 new fatalities in the last 24 hours, the daily new cases in the country remained below 20,000 for the third consecutive day.

Zee News on vaccine approval, Times Now on ‘green shoots’ in Indian economy

A quick take on what prime time TV news talked about.

Covaxin approved as it’s more likely to act against mutant Covid strain, says ICMR chief

In an interview, ICMR chief Balram Bhargava addressed questions that have been raised about the approval granted to Covaxin in the absence of efficacy data.

Bharat Biotech’s Covaxin given conditional nod based on incomplete Phase 3 trial results data

Covaxin has been recommended for restricted emergency use authorisation by a subject expert committee appointed by the Central Drugs Standard Control Organisation.

India successfully cultured UK variant of coronavirus strain, says ICMR

In a tweet on Saturday, the Indian Council of Medical Research claimed that no other country has yet reported successful isolation and culture of the UK-variant of SARS-CoV-2.

With over 21,000 new Covid infections, India’s caseload increases to 1.02 crore

The number of people who have recuperated from the disease surged to 98,60,280, while the death toll increased to 1,48,738 on Wednesday.

Drug price watchdog plans to raise ‘public health’ concerns over cocktail drugs before govt

An increasing number of fixed dose combination drugs is not desirable in the overall public interest and welfare, says the National Pharmaceutical Pricing Authority.

India’s hypertension initiative substantially improved BP control in 4 states, study finds

Study by ICMR and WHO scientists finds that a good number of patients registered with India Hypertension Control Initiative were successful in controlling their blood pressure.

On Camera

How startups are falling into lenders’ debt traps

Increasingly, lenders have stepped in where equity funding has slowed amid global market volatility. But instead of helping startups, they end up extracting a pound of flesh that outlasts the crisis itself.

Vehicles, TVs, mobile phones—PM EAC report shows rural India is catching up with urban consumers

Rural ownership of motor vehicles jumped from 19 percent in 2011-2012 to 59 percent in 2023-2024, while urban rose from 40 percent to 68 percent during the same time period, study by two members of PM-EAC says.

General secrets from frozen peaks: A Kargil veteran reveals what politically correct writers left out

At the Jindal Literature Festival, Maj Gen (Retd) Lakhwinder Singh reveals secrets from 25 years ago, speaking about the decision that outwitted Musharraf and changed the course of the war. 

A tribute to Tejas. India’s delay culture is the real enemy in the skies

It is a brilliant, reasonably priced, and mostly homemade aircraft with a stellar safety record; only two crashes in 24 years since its first flight. But its crash is a moment of introspection.